John A. Kelley, Jr., is Chairman and Chief Executive Officer of CereScan. He has been a director of Polycom since March 2000. Mr. Kelley most recently served as the Chairman, President and Chief Executive Officer of McDATA Corporation, a provider of storage networking and data infrastructure solutions. McDATA was acquired by Brocade Communications Systems, Inc., a data infrastructure company, in January 2007. Mr. Kelley started at McDATA as President and Chief Operating Officer in August 2001. Prior to joining McDATA, Mr. Kelley served as Executive Vice President of Networks at Qwest Communications from August 2000 to December 2000. He served as President of Wholesale Markets for USWest from May 1998 to July 2000. From 1995 to April 1998, Mr. Kelley served as Vice President and General Manager of Large Business and Government Accounts and President of Federal Services for USWest. Prior to joining USWest, Mr. Kelley was the Area President for Mead Corporation's Zellerbach Southwest Business Unit from 1991 to 1995, and has held senior positions at Xerox and NBI. Mr. Kelley is also a director of three venture backed start-up companies, 3Leaf Systems, StoredIQ and Aztek Networks. He serves as a senior advisor to two privately held technology companies and is a consultant for Vantage Marketplace LLC, a subsidiary of Goldman Sachs Group, Inc. He has previously served on the Board of Directors of Captaris Corporation, formerly a publicly held company in Redmond, Washington. He is also a director of Colorado Women's Vision Foundation and Mt. St. Vincent, not-for-profit organizations. Mr. Kelley holds a B.S. in business management from the University of Missouri, St. Louis.
John Q. Adams, Sr., became a member of our Board of Directors on March 12, 2009 and was elected our Vice Chairman on June 15, 2009. Mr. Adams is a renowned industry leader and innovator, and brings our Company over 45 years of experience in the pharmaceutical industry including serving as the founder and former Chairman, President and CEO of Adams Laboratories, Inc., a Fort Worth, Texas provider of specialty pharmaceuticals for respiratory care and the developer of Mucinex.™ In 1991, Mr. Adams sold the company to Medeva PLC, a London based international prescription pharmaceutical company that was subsequently acquired by Celltech Chiroscience PLC (CCP) for $914 million. In October of 1997, Mr. Adams repurchased the original Adams Laboratories, Inc. name and manufacturing facility in Fort Worth, Texas from Medeva PLC and changed the name of the company to Adams Respiratory Therapeutics, Inc. In 2005, and as Chairman, Mr. Adams implemented a $135 million initial public offering underwritten by Merrill Lynch & Co and Morgan Stanley, and soon thereafter retired as Chairman. In January 2008 and after a $2.23 billion tender offer at $60 per share, Adams Respiratory Therapeutics, Inc. was merged into a wholly owned subsidiary of Reckitt Benckiser Group plc (Lon:RB), a leading international manufacturer and marketer of branded products in household cleaning and health and personal care with annual sales of $5 billion. Prior to founding Adams Laboratories he acquired and/or co-founded Baylor Laboratories, a pharmaceutical laboratory, and Allerderm, Inc., a prescription veterinary dermatology company, which he subsequently sold to large pharmaceutical companies. In January 1998, Mr. Adams opened Rough Creek Lodge, a 39 room luxury resort and executive conference center located approximately 90 miles from Fort Worth. He is the President of J.Q. Enterprises, Inc., a holding company for his interests. In July 2007, Mr. Adams was elected to the Board of Trustees for Heidelberg College in Tiffin, OH and in April 2009 will be inducted into the Hall of Excellence of the Ohio Foundation of Independent Colleges which each year honors three distinguished graduates from 34 Ohio colleges.
Vincent D. Bradshaw, age 67, has been an independent advisor to our Company since May 1, 2008 and became our Chief Operating Officer in January 2009. Mr. Bradshaw has over 20 years of senior level management experience with AT&T, Bell Labs and USWest as well as ten years of senior level management experience with several mid-market companies. His experience includes leading corporate operations, marketing, sales, business development, customer service and government contract management functions, as well as successful engagements as a business consultant. He is a director of Centennial Food and Beverage, LLC, a wholesale distributor, and ServiSight, LLC, a management consulting firm. He has successfully built operating divisions from start-up to over $550 million in revenue.
Stanley F. McGinnis, became a member of our Board of Directors on June 4, 2009. Simultaneously since 1987 he has been the founder and Chief Executive Officer of McGinnis Group International, LLC, a Colorado limited liability company, d/b/a Secure Signals, a privately owned global risk management company specializes in cable and satellite piracy matters in Denver, Colorado (“SSI”). Mr. McGinnis, who is responsible for providing strategic direction for SSI, has been an active proponent of Anti-Piracy reform within the cable industry for over 20 years. Mr. McGinnis is a court certified expert on cable and satellite piracy matters and is a guest speaker at cable shows around the country. SSI, an established industry leader in cable and satellite piracy matters, has national contracts and/or national vendor status with Comcast, Time Warner, Charter Communications, The American Cable Television Association (representing 1100 small cable operators), and Cox Communications. SSI also consults with its clients on pre-employment services, policies and procedures, and human resources development and training. SSI was the first service company to provide a “No Cost” resolution process for cable and satellite piracy issues. Prior to founding SSI, and from 1985 to 1992 Mr. McGinnis served as Chief Operating Officer of Rochester Big & Tall Clothing, Inc., a specialty retailer in the San Francisco Bay Area in California. From 1979 to 1985 he was a principal and President of the Little Daisy Corp., a women’s specialty retailer also in the San Francisco Bay Area in California. From 1972 to 1979, Stan served as the President of Topps & Trousers Corporation, a San Francisco, California based young men’s specialty retailer with 224 stores in 24 states. Mr. McGinnis was certified as a Fraud Examiner by the Association of Certified Fraud Examiners in March 1995. In February 2003 Stan was certified as a Certified Fraud Specialist by the Association of Fraud Specialists. Stan received an Associate Arts Degree in Criminal Justice from the College of Marin (Kentfield, CA) in 1969 and attended the LaSalle School of Law. From 1992 to 1996 Stan served on the National Cable Television Association’s Office of Cable Theft. From 1979 to 1999, he was a member of the Board of Directors of the Central YMCA in San Francisco where he also served as Chairman for two years and was a founding member of that organization’s Heritage Club. Mr. McGinnis sits on the board of IPtimize (a publicly traded company) since 2007 and is the Chairman of the Compensation Committee and is a member of the Audit Committee.
Richard C. Williams, became a member of our Board of Directors on June 4, 2009. Mr. Williams is President and Chief Executive Officer of Conner-Thoele Limited, a consulting and financial advisory firm specializing in the healthcare industry and pharmaceutical segment. The firm’s primary focus is on post merger operational consolidation and restructuring, acquisition analysis, financial structuring, operational tactics development, and strategy formulation. Mr. Williams is Chairman of Adams Pharmaceuticals, and Chairman and Director of ISTA Pharmaceuticals. He is on the advisory board of EGS Healthcare Partners and was a member of the Listed Company Advisory Committee of the New York Stock Exchange. Mr. Williams previously served as Vice Chairman – Strategic Planning and a Director of King Pharmaceuticals, a NYSE emerging specialty pharmaceutical company where he was responsible for the acquisition and integration of Jones Pharma ($3.2 billion) and Medco Research. His many duties included the completion of $700 million shelf financing. Previously Mr. Williams served as Chairman and Director of Medco Research a NYSE cardiovascular development company, where he rebuilt the management team, focused the strategic direction and acquired a varied and broad technology platform. He also served as Co-Chairman and director of Vysis, a NASDAQ genetic biopharm company. Prior to founding Conner-Thoele Limitee in 1989, Mr. Williams served in a variety of progressively responsible operational and financial management positions with Erbamont N.V., a multinational ethical pharmaceutical company, and with Abbott Laboratories and American Hospital Supply Corporation. Mr. Williams received a Bachelor of Arts degree in Economics from DePauw University and a Master of Business Administration from the Wharton School of Finance.
David Stafford Johnson, is General Counsel to CereScan and directs CereScan's Forensics Division. Mr. Johnson has an extensive domestic and international corporate and entrepreneurial background in mergers and acquisitions, finance, strategic planning and structuring, intellectual property commercialization and in administering complex, multi-jurisdictional legal affairs. Mr. Johnson is licensed to practice law in the States of Arizona, Texas and Colorado and is a graduate of Dartmouth College with an MBA from Arizona State University, a Juris Doctor from the University of Arizona, and post-graduate certificates from Denver University, Harvard University and the Colorado School of Mines. Mr. Johnson has previously worked in executive legal, corporate development, strategic planning and financial and management capacities both with domestic non-profit companies and with domestic and international for-profit public and private companies in the consumer products, renewable energy, telecommunications, venture capital, oil and gas and natural resource sectors.
Learn more about brain imaging and how CereScan is helping doctors and patients. Follow us on Twitter and become a fan of CereScan on Facebook.